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By electrophoretic analysis, large quantities of an exceptionally basic, cationic 
protein (CP)  have  been found in the urine of ten consecutive cases of  mono- 
cyfic and monomyelocytic leukemia,  x The  protein  CP  has  been  isolated and 
characterized as a  relatively low molecular weight constituent with the enzy- 
matic properties of lysozyme (muramidase).  2 Increased levels of CP-lysozyme 
have  been  demonstrated  in  the  serum  of  monocytic  leukemics  by  immuno- 
chemical and enzymatic techniques  but not by electrophoresis. Evidence has 
been obtained that CP-lysozyme is the normal enzyme which is elaborated in 
excess in the monocytic leukemics. The relatively small molecular size of CP- 
lysozyme is apparently responsible for its urinary excretion. 
Materials and Metlwds 
Clinival Materla/.--The ten patients with monocytic and monomyelocyfic  (Naegeli-type) 
lenkemia (six males, four females) ranged in age from 46 to 75 years. The clinical and hema- 
tologic patterns were consistent with a diagnosis of subacute or chronic monocytic or mono- 
myelocyfic lenkemia.  The total peripheral leukocyte counts ranged from  5450 to  200,000 
with 30 to 82% monocyfic forms. Representative peripheral blood and bone marrow smears 
of two cases are shown in Fig. 1. Case 10 had a peripheral leukocyte count of  117,000 per 
mm  3 with 82% monocytic forms and was considered to have monocyfic leukemia; case 6 had 
a  peripheral leukocyte count of 68,500 with 40% monocytes and 42%  polymorphonuclear 
leukocytes,  and  was  considered  to have  monomyelocyfic  leukemia.  Preliminary electron 
microscope studies have been made in cooperation  with Dr. Henry Azar, and an  electron 
photomicrograph of the predominant cell type in the bone marrow of case 3 is shown  in Fig. 
* Studies supported by Grant CA-02332 of the National Cancer Institute, United States 
Public Health Service. 
:~ Faculty Research Associate of the American Cancer Society. 
x A report of these studies (1) was presented at the annual meeting of the American So- 
ciety for Clinical Investigation and the American Federation for Clinical Research, Atlantic 
City, New Jersey, 1 May 1966. 
s Muramidase is the designation  recommended  for lysozyme(s)  by the Commission  on 
Enzymes of the International Union  of Biochemistry (C.C.  3.2.1. 17). However,  since the 
term ,'lysozyrne" continues to be more generally employed, it will be used in this text. 
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2. Particularly noteworthy are the numerous lysosomal granules, the large Golgi zone and the 
scattered endoplasmic reticulum. 
Six of the ten cases had evidence of renal and electrolyte abnormalities, particularly hypo- 
kalemia and hyperkaluria. The mechanisms of these abnormalities and their possible relation- 
ship to the excretion of CP are under investigation, and detailed clinical, hematologic, and 
cytologic studies will be published subsequently. 
Blood and urine samples from 20 normal subjects and 250 patients with a wide variety of 
disease states, including other forms of leukemia, infectious mononucleosis, multiple myeloma 
and  other plasma  cell dyscrasias,  renal diseases,  tuberculosis and  other chronic infections, 
sarcoidosis,  carcinoma, and Hodgkin's disease were also studied. Fresh serum, separated from 
the clot within 2 hr of collection or EDTA (Versene), plasma samples were used. Heparinized 
plasma is unsatisfactory because of the formation of complexes between heparin and lysozyme. 
Normal tears were obtained from D. O., age 10, provoked by her two older siblings. 
Protein Quantilation.--24-hr urinary  collections were obtained  and  no preservative was 
added. Aliquots of whole urine were concentrated 40- to 50-fold by dialysis against 25% poly- 
vinylpyrollidone  (PVP).  Total  urinary  protein  excretion was  determined  by precipitation 
with 5% trichlor~cetic acid and Kjeldahl analysis. 
Standard  procedures  were  employed for  the  electrophoretic  (cellulose  acetate,  Spinco) 
analyses and for the starch gel and acrylamide gel electrophoretic studies.  Ultracentrifugal 
analyses were performed with the Spinco Model E  ultracentrifuge,  and  sedimentation con- 
stants calculated to infinite dilution ($20, w). 
Isolation of CP.--The urinary proteins, including CP, were initially precipitated from 24- 
hr collections by 60% saturation with ammonium sulfate. The precipitates were suspended 
in water and dialyzed against phosphate-buffered saline, pH 7.2, until free of ammonium ion. 
Saline insoluble material was discarded  and  the saline solution of protein dialyzed against 
0.1 ~  NaOH:glycine buffer, pH 9.5.  Chromatographic separation of CP from other urinary 
proteins was achieved by DEAE (diethylaminoethylcellulose) with the 0.1  ~¢ Na glycinate 
buffer, by using either column or batch separation techniques. Under these conditions, CP 
was recovered in the void volume, and the other urinary proteins were retained by the DEAE. 
More recently we have used the procedure of Alderton, Ward, and Fevold  (2)  for the iso- 
lation of lysozyme using bentonite adsorption and elution with 5% aqueous pyridine adjusted 
to pH 5.0 with sulfuric acid. 
Peptide Analyses.--Tryptic  peptide maps were made with the cooperation of Dr. Frank 
Tischendorf by the procedure of Katz, Dreyer, and Anfinsen (3) with minor modifications. 
DEAE-isolated CP samples were oxidized with performic acid and  precipitated with  10% 
trichloroacetic acid. The precipitates were washed with trichloroacetic acid, absolute ethanol, 
and ether. The oxidized CP samples were incubated for 4 hr with trypsin (Worthington Bio- 
chemical Corporation,  Freehold, New Jersey, 2 X  crystallized trypsin SF, 1 mg per 100 mg 
protein) in 0.2 ~  NH4HCO3 buffer, pH 8.2, with  phenol red  as an  indicator. Aliquots of 2 
to 3 mg were applied to Whatman 3 MM paper, and the peptides separated first by ascending 
chromatography for 22 hr in butanol:acetic acid:water (4:1: 5). This was followed by dec_ 
trophoresis for 1 hr at 2000 v in pyridine: acetic acid :water (1:10: 289) at pH 3.8.  After dry- 
ing, the peptides were stained with a ninhydrin spray. 
Amino Acid Analyses.--Amino  acid analyses were performed by Dr. Robert E. Canfield 
of the Department of Medicine of the College of Physicians and Surgeons by the method of 
Spackman,  Stein, and  Moore (4). Three DEAE-isolated CP samples were hydrolyzed by 6 
r~ HC1 for 24 hr at  110  ° C, and the amino acid analyses carried out on a  Spinco Model 120 
amino acid analyzer. Tryptophane  is destroyed  by acid hydrolysis and  is not included in 
these analyses. 
Immunologic Analyses.--Antiserum  to the DEAE-isolated CP of case 1 (Anti-CP (1))  was ELLIOTT  F.  OSSERMAN  AND  DOLORES P.  LAWLOR  923 
prepared in rabbits,  employing complete  Freund adjuvants.  Precipitin analyses were  per- 
formed  by  conventional Ouchterlony  and  immunoelectrophoretic  techniques using highly 
purified agar (Agarose, Fisher Scientific Company, Pittsburgh, Pennsylvania), at a  concen- 
tration of 1%, in Veronal buffer, pH  8.6,  ionic strength,/z  =  0.025 or 0.075. At the lower 
ionic strength, CP precipitated nonspecifically in the gel. 
Enzymatic Studies.--The  initial assays  of  CP  samples for  acid  phosptmtase,  cathepsin, 
~-glucuronidase, and lysozyme activity were kindly performed by Dr.  Zanvil Cohn of  the 
Rockefeller University, employing procedures previously detailed  (5).  fl-glycerolphosphate 
(pH 5.0)  was used as substrate for acid phosphatase; phenophthalein ghicuronide (pH 4.8) 
for/3-glucuronidase; denatured hemoglobin (pH 3.8) for cathepsin; and suspensions of washed 
Micrococcus lysodeikticus  organisms in phosphate buffer, pH  7.0 for lysozyme. Ribonuclease 
assays were kindly performed by Dr. Herbert Rosenkrantz of the Department ~Jf Microbiology 
of the College of Physicians and Surgeons, using radiophosphorus (P32)-labeled  chick embryo 
RNA as substrate. 
In this laboratory, lysozyme assays were initially performed by the methods of Smolelis 
and Hartsell (6) and Litwack (7), with 3 ml aliquots of a suspension of 25 mg of heat-killed 
M. lysodeikticus  (Worthington Biochemical Corporation,  Freehold,  New  Jersey)  in  100  ml 
of M/15 phosphate buffer, pH 6.3 with 0.1%  NaC1 and 0.3 ml of standard or unknown solu- 
tions. Twice-crystallized egg white lysozyme (Muramidase, LY 644A, Worthington Biochemi- 
cal Corporation) was used as the reference standard in the initial studies,  and serial dilution 
of DEAE  or bentonite-isolated CP  in later studies. Lysozyme activity was  measured  in a 
Bausch and Lomb  Spectronic-20 spectrophotometer as change in per cent transmission  at 
645 m# for intervals of 30 to 90 sec or 3 to 9 min following addition of the sample to  the bac- 
terial suspension, with adequate mixing. These procedures (6,  7) were found to be  valid  for 
only a  limited range of concentration and necessitated adjustment of the  concentration of 
samples to within this narrow range. 
Lyso-Plate Assay Method.--Because of difficulties encountered with conventional lysozyme 
assay methods (6,  7),  an agar plate (lyso-plate) technique was developed which has yielded 
more satisfactory results over a much wider range of concentrations. Heat-killed M. lysodeik- 
ticus organisms, suspended uniformly (Vibro-Mixer, A. G. F. Chemic Apparatgebau, Ziirich, 
Switzerland) in a small volume of phosphate buffer are added to molten (60-70°C)  1% agar 
(Agarose, Fisher) in M/15 phosphate buffer, pH 6.3 to a  final concentration of 50 mg of or- 
ganisms in 100 ml of buffered agar and poured into Petri dishes to a  depth of 4 mm. After 
the agar solidifies,  sample wells,  2 mm in diameter,  are cut with a  thin-walled brass tube, 
machined to a bevelled cutting edge. Sixteen sample wells, in four rows of four, 15 mm apart, 
can be accommodated in a  Petri dish, 85 mm in diameter. The sample wells have a  volume 
of approximately 25 /zl and are easily and reproducibly filled  by capillary tubes.  Standard 
dilutions of purified CP-lysozyme  (5,  25,  100, and 500/zg/ml)  are run with each group  of 
test samples. Mter being filled,  the plates are left at room temperature (24-26°C)  for 12 to 
18 hr, during which period zones of clearing develop in the initially translucent gel as the 
result of bacterial lysis. The diameters of the cleared zones are proportional to the log of con- 
centration of  lysozyme.  The  diameters can  be measured  directly with an  enlarger-viewer 
(Universal projector, National Instrument Laboratories, Rockville, Maryland), or the plates 
can be photographed, using the plate itself as a  "negative" in a condenser-type enlarger, and 
the diameters measured from the enlarged photographs. A  semilogarithmic plot ig made of 
the diameters given by the standard solutions, and this is used for quantitating ~g/ml) CP- 
lysozyme in the test samples. 
The time of development of the lyso-plates is not critical and can be varied over several 
hours. If the diameters are read directly rather than by photography, it is important that 
the standard and test sample measurements be made in as short an interval as possible. It is 924  SERUM  AND  URINARY  LYSOZYME  IN  LEUKEMIA 
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T~.xT-FIO. 2.  Monocytic leukemia. Electrophoretic analyses (cellulose acetate,  pH 8.6). 
Upper,  urinary proteins  (concentrated 50  times)  from  three  cases  of  monocytic leukemia 
showing the identity of the CP components. Lower,  DEAE-isolated CP's from cases 4 and 1. 
also important that the sample wells be initially filled in as short an interval as possible. The 
lyso-plates can be prepared in batches and stored at 9-10°C for 2 wk without deterioration, 
if wrapped in plastic to prevent evaporation. 
RESULTS 
Electrophoresis.--Text-fig.  1  illustrates  electrophoretic  patterns  of  the  pro- 
teins of normal serum and urine (concentrated 50-fold) and the serum and urine 
(similarly  concentrated)  of  one  of  the  cases  of  monocytic  leukemia.  In  the 
urine pattern  of  the  monocytic leukemic,  CP  is readily identified as an  elec- 926  SERUM  AND  URINARY  LYSOZYME IN  LEUKEMIA 
trophoretically  homogeneous  component  migrating  to  a  position  far  beyond 
the  cathodal boundary  of  the  gamma globulins.  The  serum  pattern  of  the 
monocytic  leukemic  shows  the  nonspecific  changes  of  decreased  albumin 
and increased  alpha-2  and  gamma globulins,  but  does not show the  CP com- 
ponent.  However, as will be noted subsequently, abnormally elevated  concen- 
trations  of  CP-lysozyme  were  demonstrated  in  the  serum  of  monocytic 
leukemics by immunologic and enzymatic methods. 
TExT-Fro. 3.  Acrylamide gel electrophoresis (Veronal, pH 8.5).  From the top, monocytic 
leukemia, case 1, whole urine (concentrated 20 times): DEAE-isolated CP's from cases 4 and 
2;  DEAE-isolated  CP  (2)  following reduction and alkylation (RA)  with cysteine amine  (2- 
mercapto-ethylamlne) and iodoacetamide. Bottom, normal serum for mobility reference. 
Text-fig.  2 shows electrophoretic patterns  of the  concentrated  urinary pro- 
teins from three  cases of monocytic leukemia, and  two of the DEAE-isolated 
CP's. The identity of the electrophoretic mobilities of the CP's is evident. The 
pattern  of the  DEAE-isolated  CP  of case  1 shows a  minor component on the 
anodal side of the  main CP  peak which  was identified  immunoelectrophoreti- 
cally as a  small quantity of low molecular weight gamma-u. As illustrated  in 
Text-figs. 1 and 2, the urine protein patterns of all cases of monocytic leukemia 
demonstrated significant quantities of albumin, alpha, beta, and gamma globu- 
lins,  in  addition  to  CP.  The  24-hr urinary protein  excretion  in  these  cases ELLIOTT  F.  OSSERMAN  AND  DOLORES  P.  LAWLOR  927 
ranged from 1.4 to 6.6 g, of which CP constituted 16 to 40% (0.6 to 2.6 g/day). 
The prominent beta globulin constituent seen in the case 4 urinary pattern in 
Text-fig. 2 was immunologically identified as transferrin. 
Text-fig. 3 shows acrylamide gel electrophoretic analyses (Veronal buffer, pH 
8.5)  of whole urine and DEAE-isolated CP samples prior to and following re- 
duction  and  alkylation  with  0.02  M cysteine  amine  (2  mercapto-ethylamine) 
and iodoacetamide. In acrylamide gel, there was no evidence of heterogeneity of 
either the native or reduced  CP, as indicated  by the absence of banding, and 
TExT-FIG. 4.  Ultracentrifugal analyses of CP-DEAE  (2)  and  CP-DEAE  (4). Aqueous 
solutions, 6.7 mg/ml Spinco, Model E, 59,780 RPM. Direction of sedimentation, right to left. 
the CP samples from three different cases again showed identical electrophoretic 
mobilities. 
Ultracentrifugation.--Ultracentrifugal  analyses  of  two  DEAE-isolated  CP 
samples are shown in Text-fig. 4.  The sedimentation patterns of the  two CP's 
are identical with symmetrical boundaries and there is no evidence of hetero- 
geneity. The sedimentation constant (S20,w) of both, calculated to infinite dilu- 
tion,  was  1.8S,  corresponding to a  molecular weight of the  order of 14,000  to 
15,000.  Ultracentrifugal analyses of two other CP samples yielded S20,w values 
of 1.8 and 2.0S.  The variability is attributed  to methodologic error. 
Tryptic Peptide Maps.--Peptide  maps of  the tryptic digests of two DEAE- 928  SERUM  AND  URINARY  LYSOZYME IN  LEUKEMIA 
isolated  CP's are shown in Text-fig. 5.  The over-all similarity of these  maps is 
evident. A  total  of 19  ninhydrin-positive  peptides  was identified in  CP-DEAE 
(2) and 18 in CP-DEAE  (4). The single peptide (P2)  not detected in  CP-DEAE 
(4) is only faintly visible in the map of CP-DEAE  (2), and its absence from CP- 
DEAE  (4)  may  be  due  to  methodologic  limitations.  The  number  of  tryptic 
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Moles of amino acid per 
100 moles 
CP (t)  CP (2)  CP (4) 
3.22  4.81  4.17 
0.72  1.38  0.82 
10.61  9.24  10.69 
14.47  13.22  14.55 
4.18  4.89  4.48 
4.72  5.43  5.04 
7.93  8.74  8.32 
2.20  3.82  2.50 
9.22  10.36  8.39 
11.77  9.61  11.02 
5.35  4.17  4.64 
7.08  6.32  6.61 
1.63  1.50  1.81 
4.06  3.62  4.16 
6.35  6.41  5.94 
4.72  4.25  4.87 
























Amino acid iesidues per 
mole 
Human saliva  Eggwhitc 
LZM;~  LZM§ 
5-6  6 
1  1 
11  +  1  11 
18  4-  1  21 
6-t-1  7 
64-  1  10 
94-1  5 
2  2 
12  4-  1  12 
12  -4-  1  12 
6  8 
7  6 
1-2  2 
4-5  6 
8  8 
5  3 
2  3 
54-1  6 
12i  4-  5  129 
* Calculated on the basis of 125 residues,  including an estimated 5  tryptophane  residues. 
Data  of Joll~s  et al.  (8)  estimated from analyses of human salivary, milk, spleen,  anJ 
leukocytic lysozymes. 
§ Data of Canfield (9). 
peptides  is  consistent  with  the  sum  of lysine  and  arginine  residues  (5  +  12) 
found by amino acid analyses. 
Amino Acid Analyses.--Amino  acid  analyses  of  acid  hydrolysates  of  three 
DEAE-isolated CP samples are shown in Table I. The results of the  individual 
analyses are expressed as moles of amino acid per 100 moles. Tryptophane is not 
estimated  because  of its destruction by acid hydrolysis, but a  peak correspond- 
ing to the position of tryptophane  was present in the chromatograms of all three 
samples,  indicating  its  presence  in  CP.  In  general,  the  analyses  of  the  three ELLIOTT  F.  OSSERMAN  AND  DOLORES P.  LAWLOR  929 
TExT-Fro. 5. Pepfide maps of tryptic digests of two DEAE-isolated CP's. Points of appli- 
cation of samples are at the lower left corners. Ascending chromatography in butanol:acetic 
acid for 24 hr in the vertical axis was followed by electrophoresis (2,000 v, 1 hr; pyridine:acetic 
acid pH 3.6) along the horizontal axis. Ninhydrin stain. PR identifies the phenol red marker. 930  SERUM  AND  URINARY  LYSOZYME  IN  LEUKEMIA 
samples are in agreement and show no differences which cannot be accounted 
for by methodologic error. The ratios of basic to acidic amino acid residues for 
the three samples were 0.65,  0.70,  and 0.68,  respectively. 
Also tabulated in Table I  are the estimated minimal number of amino acid 
residues in CP calculated from the averaged values of the three analyses on the 
basis of one histidine and two methionines with the further assumption of five 
tryptophanes. The tryptophane estimate is based on the data of Joll~s and co- 
workers (8) for several human lysozymes. These data and the data of Canfield 
(9) for egg white lysozyme are also shown in Table I. A close correspondence is 
apparent between the  CP analyses and the values obtained for other human 
lysozymes by Joll~s et al.  (8). When compared with egg white lysozyme, these 
proteins show several significant differences, particularly the higher glutamic 
and tyrosine, and lower serine and aspartic contents. 
Immunologic Analyses.--Immunoelectrophoretic  and Ouchterlony analyses of 
CP samples are shown in Text-figs. 6 and 7. As seen in the top patterns in Text- 
fig. 6, the rabbit antiserum to CP  (1), prior to absorption with normal serum 
(Anti-CP  (1)  unabsorbed)  contained antibodies  to  gamma-G globulin,  prob- 
ably  as  a  result  of  the presence of a  small amount of low molecular weight 
gamma-u in the sample of DEAE-isolated CP (1) used for immunization. The 
anti-gamma globulin activity was removed by absorption with normal serum. 
When the immunoelectrophoretic analyses were performed in agar with a low 
ionic concentration (/~ =  0.025), CP migrated only slightly in the gel and precip- 
itated  in  the  form of two chevrons on the cathodal side of the antigen  well. 
This precipitation is  probably due to interaction of the basic  CP  with  acidic 
groupings  in  the  agar  matrix,  in  combination  with  a  lesser  solubility of  CP 
at low salt concentrations. When the immunoelectrophoretic analyses were per- 
formed with a salt concentration of 0.075  (middle and lower patterns, Text-fig. 
6), CP migrated to the expected postgamma, cathodal position and was precipi- 
tated by the Anti-CP(1)  antiserum. The unabsorbed Anti-CP  (1)  also precipi- 
tated two unidentified constituents in the whole urine of case  1,  one of which 
nligrated to the same cathodal region as CP. Neither of these constituents was 
detectable in the  DEAE-isolated  CP  (1)  sample  used  for  immunization,  by 
either  the  absorbed or the unabsorbed Anti-CP (1) antiserum  (lower pattern, 
Text-fig. 6). 
The Ouchterlony analyses illustrated in Text-fig. 7 were all made with Anti- 
CP  (1)  absorbed with normal serum. These analyses demonstrate reactions of 
identity among all CP samples with no detectable spurs to indicate structural 
differences. Also shown in  the  middle  pattern  in  Text-fig.  7  are  reactions of 
identity  between two  CP's  and  a  component  in  normal  tears,  presumably 
lysozyme. The lower pattern in Text-fig. 7 demonstrates that the CP's in the 
serum, urine, and white blood cells  (sonicated buffy coat preparation) of case 8 
are antigenically identical. Although a  visible  precipitin  arc  did  not  develop TExT-FIG.  6. Immunoelectrophoretic analyses. 
Top patterns, ionic strength,/~ =  0.025.  Normal  serum and whole urine of case 1 (concen- 
trated  20 times), developed with horse antiserum to normal serum and rabbit  antiserum to 
CP  (1), prior to absorption. Unabsorbed Anti-CP (1)  precipitates the gamma-G globulin of 
normal serum and case 1 urine. At this low ionic strength, CP precipitates as a  chevron (e,u-) 
on the cathodal side of antigen well. 
Middle patterns,  ionic strength, /~  ~  0.075.  Serum  and  urine  of case  1  developed with 
Anti-normal serum and with Anti-CP (1)  absorbed with normal serum  (-- NS). AntiCP  (1) 
--  NS demonstrates three components in the urine of case 1: a  major constituent,  1,  identi- 
fied as CP; a small component, g, in the same cathodal region; and a  third arc, 3, in the beta 
mobility range. Components 2 and 3 are unidentified. 
Lower pattern,  ionic strength, /z  ~  0.075.  DEAE-isolated CP  (1),  developed with Anti- 
CP  (1), prior to and following absorption with normal serum. 
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TExT-FIG.  7.  Ouchterlony analyses, developed  with  rabbit  antiserum  to  the  DEAE-iso- 
lated CP of case 1  (Anti-CP (1)), absorbed with normal serum. 
Top, reactions of identity among five of the DEAE-isolated CP's. 
Middle, further confirmation of reactions of identity among CP's and with a  component, 
presumably lysozyme in normal tears. B-F is the concentrated (50X) urine of a case of Boeck's 
sarcoid with increased urinary lysozyme. 
Lower, demonstration of CP in the serum (S), urine (U), and sonicated buffy coat (WBC) 
of case 8, and their identity with CP  (4).  No preclpltin line is seen with normal serum  (NS) 
but a  bending of the end  of the  U  (8)  preclpitin line adjacent to  the NS well  indicates the 
presence of a  small amount of CP in normal serum. ELLIOTT  F.  OSSERMAN AND  DOLORES P.  LAWLOR  933 
with  normal serum (NS),  bending of the end of the U  (8)  precipitin line adja- 
cent to the NS well indicates the presence of a  small amount of  CP  in normal 
serum. 
Enzyme Assays; Lysozyme Activity  of CP.--Assays  for  enzymatic activities 
performed on the ammonium sulfate precipitates of the total urinary proteins of 
TExT-FIG. 8. Demonstration of lysozyme activities of DEAE-isolated CP (4) and bento- 
nite-isolated CP (10), compared with equal concentrations (/zg/ml)  of twice-crystallized  hens' 
egg white lysozyme (EW-LZM). Plate assay (lyso-plate)  method, with heat-killed M. ly~o- 
deikticus incorporated in phosphate-buffered (pH 6.3)  agar gel.  Samples  (25 #1)  are placed 
in wells, 2 mm in diameter, and the plate photographed after 16 hr at 25°C. Dark zones around 
sample wells are zones of clearing due to bacterial lysis~ and are proportional to the concert- 
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the monocytic leukemics showed extremely high  lysozyme activity and  very 
low levels of acid  phosphatase,  ~-glucuronidase, cathepsin,  and  ribonuclease. 
Assays of the isolated CP's demonstrated only the lysozyme activity. 
When the lysozyme assays  were performed by standard procedures (6,  7), 
using suspensions of M. lysodeikticus organisms in phosphate buffer (pH 6.3) 
with 0.1% NaC1,  the lyric activity of the isolated CP samples was 2 to 3 times 
greater per unit weight than the activity of twice-crystallized egg white lyso- 
zyme. With the lyso-plate assay method (Text-fig. 8), the lysozyme activity of 
the isolated CP's was 8 to 12 times greater than that of equivalent concentra- 
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TExT-FIG. 9.  Lyso-plate analysis: semilogarithmic relationship between CP-DEAE (4) 
concentrations (5 to 500/~g/ml) and the diameters of the zones of clearing, measured from 
an enlarged photograph of the plate illustrated in Text-fig. 11. 
Text-fig. 9 demonstrates the linear semilogarithmic relationship between the 
concentration of CP  (ranging from 5 to 500 #g/ml) and the diameters of the 
lyso-plate lyric zones. The diameters plotted in Text-fig. 9 were measured from 
an enlarged photograph of the plate illustrated in Text-fig. 11. Equally satisfactory 
standard curves are obtained by direct measurements of lytic zone  diameters 
using an enlarger-projector. 
Inhibition  of the Lysozyme Activity  of CP by Anti-CP Antiserum.--The lyso- 
plate shown in Text-fig. 10 demonstrates that  the rabbit antiserum to CP  (1) 
inhibits the lysozyme activity of CP (4), human saliva, and tears as evidenced 
by flattening of their respective lytic zones on the side adjacent  to the anti- 
serum. In contrast, Anti-CP did not inhibit the activity of egg white lysozyme, 
indicating structural differences between the human and egg enzymes. No anti- 
lysozyme activity was found in a goat or horse antiserum to human serum, but ELLIOTT ~.  OSSERMAN  AND  DOLORES  P.  LAWLOR  935 
both of these sera as well as the rabbit serum (Anti-CP) showed intrinsic lyso- 
zyme activity. 
Serum and Urinary Lysozyme in Monocytic Leukemia.--Text-fig. 11 illustrates 
lyso-plate analyses of normal serum and urine,  and the serum and urine  (un- 
concentrated)  of three  cases  of monocytic leukemia.  Normal serum shows ap- 
proximately 7  #g/ml of CP-lysozyme activity, and the activity ir~ normal urine 
is barely detectable.  In the  monocytic leukemics, the serum CP concentrations 
ranged from 40 to 150/zg/ml, and urine CP concentrations from 25 to 420 #g/ml. 
TEXT-FIc. 10. Lyso-plate demonstration  of inhibition of the lysozyme activity of CP (4), 
human saliva, and tears by Anti-CP  (5) antiserum, and the absence of detectable inhibition 
of egg white lysozyme activity by this antiserum.  Goat (GAHS) and horse (HAHS) antisera 
to human serum show no antilysozyme activity but both of these sera as well as the rabbit 
serum (Anti-CP) show intrinsic lysozyme activity.  Photographed  after 30 hr development. 
As shown in the bottom row in Text-fig.  11,  serial  serum samples from case 3 
over a 6 month period demonstrated a small but significant increase in CP con- 
centration from 48 to  59 #g/ml. 
Serum  and  Urinary  Lysozyme in  Other Disease States.--With  the  lyso-plate 
technique,  an  increase  in lysozyme activity was demonstrated in  the urine  of 
patients  with  chronic renal  diseases,  particularly the nephrotic syndrome and 
urinary tract infections,  but the amount of lysozyme in these  urines  was con- 
siderably lower (3 to 5/~g/ml)  than  that  of the monocytic leukemics. Moder- 
ately elevated  (10 to 30 #g/ml)  serum  and urinary lysozyme levels  were  also 936  SERUM  AND  URINARY  LYSOZYME IN  LEUKEMIA 
found  in  other  chronic  infections  and  sarcoidosis.  In  some  of  these  cases,  the 
serum  lysozyme  activity  approached  the  lower  range  but  not  the  median  or 
higher values observed  in  the monocytic leukemics.  Normal  levels were  found 
in myelocytic leukemics without  associated monocytosis,  and  reduced  levels in 
TExT-FIo.  11. Lyso-plate assays of normal serum and urine and the serum and  urine of 
three cases of monocytic leukemia. The serum  and urine samples are unconcentrated.  Con- 
centrations of CP DEAE (4), ranging from 5 to 500 ttg/ml, are in the top row for comparison. 
In the bottom row, serial serum samples from case 3, over a 6 month period show a small but 
significant increase in lysozyme activity. 
cases of lymphatic  leukemia.  Lysozyme levels in infectious mononucleosis were 
within  the normal  range. 
DISCUSSION 
Chemistry and Distribution  of Lysozymes.--In  1922,  Fleming (10)  reported  to 
the  Royal  Society of London  the discovery of a  "remarkable  bacteriolytic  ele- ELLIOTT F. OSSERMAN  AND  DOLORES  P. LAV/LOR  937 
ment found in tissues and secretions" in a communication equally remarkable 
for its clarity and scope. The substance was designated "lysozyme" and the 
strain of gram-positive cocci found to be particularly susceptible to its lytic 
action as Micrococc~  lysodeikticus. Among the observations reported in  this 
first paper (10) were the widespread distribution of lysozyme and its particu- 
larly high concentration in hens' egg white, human tears, saliva, sputum, and 
nasal secretions. Significant activity was also found in blood serum and leuko- 
cytes. A particular association of lysozyme with leukocytes was suggested by 
its presence in "sero-pus from a cold abscess" (presumably tuberculous) and in 
abnormal urine "cont~inlng much albumin and pus," but not in normal urine. 
In a second paper in 1922,  Fleming and Alli.~on (11) reported the presence of 
lysozyme in empyema pus as further evidence of its relationship to leukocytes. 
In human tissues, the highest concentrations were found in cartilage and stom- 
ach,  and  lower concentrations in  intestines,  kidney,  liver,  tonsil, and brain. 
No activity could be demonstrated in normal cerebrospinal fluid. In tears, the 
lysozyme concentration was estimated as 100 to 150 times greater than that of 
seruIIL 
The apparent similarity or identity of the lysozymes in different human tissues and 
body fluids and their similarity to the lysozyme of egg white was indicated by observa- 
tions with lysozyme-resistant strains of M. lysodeiktic~. Org~nlsms  grown  in  the 
presence of and resistant to egg white lysozyme were found to be comparably resistant 
to the lysozyme activity of human tissues and secretions. In subsequent studies  (12), 
lysozyme-resistant straln.q of streptococci were found to be resistant to intracellular 
digestion by leukocytes, and it was postulated that lysozyme was the substance in 
leukocytes responsible for bacterial digestion. 
Lysozyme was characterized by Fleming (10, 11) as nondialyzable, soluble in 
water and  weak saline solutions,  insoluble in alcohol and ether,  resistant to 
heat and desiccation, stable on prolonged storage at room temperature, and 
readily absorbed by charcoal and fibrin. Most of the properties of the lysozyme 
in human tissues and secretions were apparently similar to those of egg white 
lysozyme. 
Following these observations,  no significant progress was made in the further char- 
acterization of lysozyme until Meyer and his coworkers (13) developed a procedure 
for purifying the enzyme from acetone-dried egg white by precipitation with flaviauic 
acid.  The enzyme thus obtained was  identified  as  "a basic  polypeptide, having a 
nitrogen content of 15.3 per cent and giving a number of protein reactions." Subse- 
quently, Alderton, Ward, and Fevold (2) utilized the adsorbability property of lyso- 
zyme to effect its isolation from egg white, employing bentonite (finely divided moril- 
lonite clay) as the adsorbent, and eluting with 5 % pyridine adjusted to pH 5.0 with 
sulfuric acid.  By this procedure, lysozyme was isolated  in high yield (85 to 90%), 
and characterized as a  basic  protein (isoelectric point between pH  10.5 and  11.0) 
of low molecular weight (about 17,000). It was further demonstrated that the enzyme 
could be crvstMllzed at the isoelectric region (pH 10.8), at pH 7.0, and in acid solu- 938  SERUM  AND  URINARY  LYSOZYME  IN  LEUKEMIA 
tions (pH 3.5 to 5.0). The isolation procedure devised by Alderton et al. (2) has been 
extensively  employed in  subsequent  investigations,  including  the  present studies. 
Wetter and Deutsch (14), using this method, prepared 7 times-crystallized egg white 
lysozyme which was found to have an isoelectric point of 11.35 at 0.1 ionic strength, 
an electrophoretie  mobility at pH 8.6 in diethyl-barbiturate buffer of +2.90  ×  10  -s 
cm  2 v  -1 see  -1, and a sedimentation constant (S20.w) of 2.11 at a protein concentration 
of 1.3 g per cent. From the sedimentation and diffusion constants and the apparent 
specific volume, a molecular weight of 17,200 was calculated.  A rabbit antiserum to 
the purified lysozyme was found to inhibit its enzymatic activity. 
More recently, detailed studies of the amino acid composition, tryptic and chymo- 
tryptic peptides and amino acid sequence of egg white lysozyme have been carried 
out by JoU~s (8, 15-19), and Canfield (9, 20-22), and their associates. These studies 
have established  that egg white lysozyme is a single polypeptide chain of 129 amino 
acid residues (Table I) with lysine in the N-terminal and leucine in the C-terminal 
position. The molecular weight of egg white lysozyme based on structural determina- 
tions is 14,307 (9). There are six half-cystines  (three disulfide bridges) and six tryp- 
tophane residues. Bewley and Li (23) have demonstrated inactivation of the enzyme 
if the tryptophanes are hydroxymethylated and have suggested that tryptophane(s) 
may be present in  the active site.  A three-dimensional  structure of hen egg white 
lysozyme has  been derived by X-ray crystallographic  analyses  at  2  A  resolution 
(24, 25), and preliminary evidence suggests that the tryptophane residues in positions 
62, 63, and 108 may be involved in the substrate binding site. 
Because of the availability of large quantities of hen egg white lysozyme, this 
protein has been the most extensively studied to date. Some studies, however, 
have been performed on lysozymes isolated from other sources, including plants, 
Ficus and Papaya latex (26,  27),  rabbit, rat and dog spleen and kidney (28,  8, 
17), human kidney (29), placenta (30), saliva (8, 31), and normal and leukemic 
leukocytes (8, 32) by Joll~s and his associates. These studies, which have been 
reviewed by Joll~s  (33), have established certain chemical and structural simi- 
larities among different lysozymes, including acid and heat stability, basicity 
with isoelectric points in the range of pH  10 to  11, and  comparable substrate 
specificities. The lysozymes of rabbit and dog spleen have been shown to have 
the same N-terminal lysine and C-terminal leucine as the hen egg white enzyme, 
but distinctly different tryptic peptide maps. 
Amino acid analyses of lysozyme isolated from human placenta (30), saliva 
(31),  and  leukocytes  (8,  32)  have  yielded comparable results  corresponding 
closely with the analyses of CP-lysozyme in the present studies (Table I). These 
data, along with the additional immunochemical evidence of the identity of CP- 
lysozyme with the lysozyme of normal tears (Text-fig. 7), indicate the probable 
identity of the enzyme in all human tissues and secretions. 
The dissimilarities between the human and egg white lysozymes are evident 
in their amino acid compositions (Table I) and were further substantiated by 
the failure of the antiserum to CP-lysozyme to inhibit the activity of the egg ELLIOTT  1~.  OSSERMAN  AND  DOLORES  Po  LAWLOR  939 
enzyme (Text-fig. I0). In similar studies,  Glynn and Parkman  (34)  have re- 
ported that a  rabbit antiserum to rat lysozyme inhibited the homologous en- 
zyme but failed to inhibit egg white or human lysozyme. 
With respect to their relative enzymatic activities, Joll~s and his associates 
(30,  31, 33), found that the human lysozymes had approximately 3 times the 
activity (units per/~g) of hens' egg lysozyme when assayed with suspensions of 
M.  lyso~ikti, cus  in  phosphate  buffer (pH 5.2).  Comparable  results  were ob- 
tained in the present studies when similar assay methods were employed. How- 
ever, by the lyso-plate method, CP-lysozyme was found to have 8 to 12 times 
the activity of hen's egg white lysozyme at equivalent concentrations. This dif- 
ference may in part be due to differences in the diffusability of the two enzymes 
in the agar medium, possibly reflecting differences in molecular size, polymer 
formation, or interactions with acidic groups in the agar matrix. These param- 
eters are presently being studied. 
The Lysozyme Substrate.--The specific substrate of lysozyme was first isolated  by 
Meyer et al.  (35) and characterized  by these workers  (35, 36), and by Epstein and 
Chain  (37) as  a  polymerized  mucopolysaccharide  which  is  depolymerized  by the 
enzyme through the hydrolysis of glucosidic linkages with the release of a reducing 
sugar and acetylhexosamine.  Subsequent  studies of Salton and Ghuysen (38) demon- 
strated that the lysis of cell wall preparations of M.  lysodeikticus, B. megatherium, 
and Sarcina lutea yielded dialysable and nondialysable products; the former consisted 
in part of a disaccharide of N-acetylglucosamine  and N-acetylmuramic acid, and the 
latter of compounds with molecular weights of 10,000 and 20,000. Salton and Ghuysen 
(38) identified the disaccharide  as N-acetylglucosaminyl-/5(1 --* 6)-N-acetylmuramic 
acid. They (38) also detected a tetrasaccharide which is a dimer of the disaccharide 
joined by a fl(1 --* 4) linkage. At present, this tetrasaccharide is considered to be the 
specific substrate of lysozyme with the enzyme having fl(1 --* 4)-N-acetylglucosamini- 
dase and/or fl(1 --* 4)-muramidase action. The bacterial cell wall is thought to have a 
basic skeleton of alternating N-acetylmuramic acid and N-acetylglucosamine  residues 
with alternating fl(1 --~ 4) and fl(1 --* 6) linkages. Some of the muramic acid residues 
have  substituent  peptides  accounting for  the  nondiaiyzable  products  yielded  by 
lysozyme action on the cell wall substrate (38). 
In M. lysodeikticus, Sarcina lutea, and other bacteria which are particularly suscepti- 
ble to lysozyme action, the specific substrate is apparently located in a position di- 
rectly accessible to the enzyme. In other organisms, the polysaccharide substrate may 
be present but inaccessible, because  of surface  lipids,  proteins, and other polysac- 
charides. These organisms are resistant to lysozyme unless the substrate is rendered 
accessible by other enzymes (e.g. lipases, proteinases)  or other agents (e.g. comple- 
ment, antibody). Thus, in the host, lysozyme may act synergistically with other agents 
against  a  wide  variety of bacteria including  some  which  are apparently resistant 
when exposed to the enzyme in vitro (17, 33, 39, 40). 
Leukocyte.s,  Monocytes,  Macrophages,  and Lysozyme.--As  previously noted, 
the  original observations  of Fleming  (10,  11)  established  the relationship of 940  SERUM[  AND  URINARY  LYSOZYM:E  IN  LEIrK.EMIA 
leukocytes to lysozyme. Subsequently, identification of the particular popula- 
tions of leukocytes containing lysozyme has been the objective of several studies 
(34, 41-44) but the question of whether the enzyme is elaborated exclusively by 
a specific group of cells, possibly monocytic leukocytes, or whether both mono- 
cytes and polymorphonuclear leukocytes contain lysozyme, is still not clearly 
resolved. In great measure, the failure to clarify this issue is due to the inherent 
difficulties in obtaining "pure" cell populations for study, and this in turn is 
responsible for the  fact  that  the  precise interrelationship of monocytes and 
polymorphs is not clearly defined. 
In 1940, Barnes (41) compared  thoracic duct lymphocytes and peritoneal leuko- 
cytes of rabbits and cats with respect to their content of lysozyme,  cathepsin,  nu- 
ciease, and lipase and found significantly higher levels of all enzymes in the peritoneal 
leukocytes.  Since these leukocytes were harvested from saline washings of the peri- 
toneum, they clearly represented a mixed population of ceils (polymorphs, monocytes, 
histiocytes,  etc.), and the lysozyme-containing  ceils could not be specifically identi- 
fied. The apparent absence of lysozyme in lymphocytes, however, was well documented 
and later confirmed by Flanagan and Lionetti (42) in studies of lysates of normal hu- 
man blood.  In these studies  (42), lysozyme levels were found to correlate with the 
total leukocyte count, but not with any specific fraction in the differential  count. 
Brumfitt and Glynn (43), in studies sirmlar to those previously reported by Fleming 
and Allison (12), showed that human polymorphonuclear  leukocytes and rat peritoneal 
maerophages had the capacity to phagocytize and destroy lysozyme-sensitive strains 
of M.  lysodeikticus, whereas  lysozyme-resistant  strains  were phagocytized but not 
destroyed. In subsequent  studies,  Glynn and Parkman (34) demonstrated binding of 
a  rabbit anti-rat lysozyme antiserum to the cytoplasmic granules  of rat peritoneal 
leukocytes and macrophages,  using  an indirect immunofluorescence method. These 
studies  were interpreted as providing further evidence that both macrophages  and 
polymorphs contain lysozyme. More recently, Speece (45) described an histochemical 
procedure for demonstrating lysozyme in tissues. Frozen sections of tissues are over- 
layered with a suspension of M. lysodeil~ic~.s in agar and stained with Alcian blue and 
basic fuehsin. Intact organisms were found to stain blue and protoplasts, red. Using a 
modification of this method, Briggs and associates (44) have studied peripheral blood, 
huffy coat, and bone marrow preparations and found lysozyme activity in monocytes, 
polymorphs, and polymorph precursors.  No lysozyme was detected in lymphocytes, 
plasma cells, basophils, mast ceils, or marrow retieuloendothelial cells. In these studies 
(44), monocytes appeared to have the highest content of lysozyme. 
Considerable evidence has been assembled which apparently establishes that 
monocytes are the circulating precursors of tissue macrophages (46-52), alveo- 
lar  macrophages  (53-55),  and  the  epithelioid and  giant  cells of tuberculous 
granulomas (49, 56, 57). Much of the earlier evidence for these cellular interre- 
lationships was derived from morphologic observations of fixed tissues and cell 
cultures and from studies of the migration of phagocytic cells labeled with car- 
bon particles,  dyes,  or other markers.  More recent studies utilizing  enzyme ELLIOTT  ~.  0SSERMABT  AND  DOLORES  P.  LAWLOR  941 
markers, particularly lysozyme (43, 58-62) have provided further decumenta- 
tion of the transformation of monocytes into macrophages and certain of the 
cellular constituents of granulomas. 
In 1961, Myrvik and coworkers (58) described a method for harvesting large num- 
bers of alveolar macrophages  from normal rabbit lungs and demonstrated (59) that 
the lysozyme content of these alveolar macrophages  (2000 to 4000 #g/ml of packed 
cells) was many times greater than that of peritoneal macrophages.  In subsequent 
studies  (60), an even higher lysozyme content was found in alveolar macrophages  of 
rabbits with granulomatous lung disease induced  by vaccination with BCG strain 
tubercle bacilli.  Cohn and Wiener (5) have also observed a 2- to 3-fold increase in 
lysozyme content of rabbit alveolar macrophages  after BCG chAnenge and further 
demonstrated a  comparable  increase in several  other enzymes including  acid phos- 
phatase, llpase,  cathepsin,/~-ghicuronidase,  ribonudease, and esterase in these cell 
preparations. By differential centrifugation of cell lysates, 60 to 80% of these enzymes 
were localized in the postnudear (lysosomal) fraction which sedimented  at 15,000 g. 
In subsequent studies  (63), rdease of enzymes including  lysozyme into the solubte 
fraction was demonstrated following ingestion of heat-killed E. cdi apparently as a 
consequence of granule (lysosome) rupture. More recently, Carson and Dannenberg 
(40) reported an increased lysozyme content in both alveolar and peritoneal macro- 
phages of rabbits challenged intravenously with heat-killed  M. tuberculosis but they 
could not demonstrate an increase in protease or lipase. 
The multiplicity of enzymes found in leukocytes and macrophages and the 
variable changes in their concentrations in response to different stimuli raises 
the question of whether there are several genetically distinct cell populations 
with specific constituent enzymes, or whether a  single cell line arising from a 
common precursor can respond to a  particular challenge with a  specific pat- 
tern of enzymes. At present, this question cannot be resolved with the evidence 
available. 
Monocytes,  Macrophage~,  Lysozynw,  amt  Tuberculosis.--That  monocytes, 
macrophages, and their contained lysozyme may play a significant role in host 
defenses against  mycobacteriai infections has been suggested by several ob- 
servations in experimental animals (40, 57, 60, 64, 65). 
In 1951, Myrvik and Weiser (64) demonstrated that the serum of rabbits immunized 
with heat-killed tubercle bacilli  in  Freund adjuvants was  strongly tuberculostatic 
against the BCG strain of M. tuberculosis and that the active principle was qimilar to 
egg white lysozyme in its heat stability, adsorption behavior,  and antibacterial spec- 
trum. These observations  were followed by the studies  of the lysozyme content of 
alveolar  macrophages  of  BCG-challenged  rabbits,  previously  described  (60-62). 
Myrvik's findings have been confirmed by Tsuji (65) who further demonstrated that 
the increase  in lung  (alveolar)  macrophages  in rabbits immunized  with BCG and 
Mycobaaerium phlei was  associated  with  increased  mycobacteriostatic activity of 
lung tissue. It is of further interest that de Wijs and Joll6s (66) have identified  the 942  SERUM  AND  URINARY  LYSOZYME  IN  LEUKEMIA 
polysaccharide lysozyme substrate in cell wails of three atypical mycobacterial strains, 
M. phlei, M. fortuitum,  and M. kansasi, and have demonstrated the susceptibility 
of these strains to human milk lysozyme as well as hens' and duck egg white lysozyme. 
Similar studies on M. tuberculosis have been hindered by the difficulties in isolating 
cell walls of these organisms due to their high lipid content. 
In  man,  there  is  likewise  considerable evidence of a  relationship between 
monocytes, lysozyme, and mycobacterial infections. 
After the observations  of Cunningham  et al.  (57) of monocytosis in tuberculous 
rabbits, Medlar (67) and Flinn and Flinn (68) demonstrated  a significant increase in 
peripheral  blood monocytes in patients with active tuberculosis, and this has been 
confirmed in subsequent studies (69, 70). Gibson has reported  (71) a remarkable case 
of  disseminated  tuberculosis associated  with a  monocyfic leukemoid reaction  and 
monocyte counts as high as 36,000 per mm  3. Post-mortem  examination revealed ex- 
tensive monocytic proliferation in the tuberculous granulomas. 
With regard to lysozyme in human tuberculosis, Kerby and Chaudhuri (72) 
demonstrated increased  lysozyme activity in  the  plasma  and  leukocytes of 
tuberculous subjects, comparable to that found in tuberculous rabbits by Myrvik 
and Weiser (64). Kerby and Chaudhuri's findings (72) have been confirmed by 
Finch, Lamphere, and Jablon (73) and by observations'on a  small number of 
tuberculous subjects in the present studies. 
In Boeck's sarcoid, another granulomatous disease possibly related to tuber- 
culosis, monocytosis has been reported in association with active progression 
(70,  74)  and coincident with an unusual response to repeated challenge with 
Kveim antigen (75).  In the present studies, significant increases in serum and 
urinary lysozyme were found in four of fifteen cases of Boeck's sarcoid (Text- 
fig. 7) but a correlation with peripheral monocytosis was not apparent. 
Lysozyme in Other Chronic Infections and Renal Diseases.--With respect to 
the role of lysozyme in other disease states, Meyer and Prudden and their as- 
sociates (76-78)  demonstrated increased lysozyme activity in the gastric juice 
of patients with peptic ulcers and in the stools and colonic mucus of patients 
with ulcerative colitis and regional enteritis. On the basis of these observations, 
lysozyme was postulated to be an etiological factor in ulcerative intestinal dis- 
eases.  However, subsequent studies by these workers (79)  and by Hiatt et al. 
(80)  established that the invading granulocytes were the principal  source of 
lysozyme in these conditions rather than the gut wall,  indicating that the in- 
crease in lysozyme probably represented a  secondary rather than a  primary 
factor. 
An association between lysozyme and renal disease was initially suggested in 
Fleming's report  (10)  of increased lysozyme in  abnormal urine  "containing 
much albumin and pus." Subsequent studies (81-85)  have further documented 
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Wilson and Hadley (81) and Burghartz and Boosfeld (82) demonstrated increased 
lysozyme activity in the urine of some but not all nephrotic children. The degree of 
hyperlysozymuria could  not be correlated with  the extent of proteinuria or other 
parameters of renal functional impairment. These studies were extended by Prockop 
and Davidson (83) who reported increased urine and serum lysozyme levels in patients 
with  a  variety of renal  diseases  including  pyelonephritis,  glomerulonephritis,  and 
nephrosis. Again, no correlation was evident between the amount of urinary lysozyme 
and the severity of proteinuria or pyuria. Hyperlysozymuria has also been reported 
in association with the nephropathy of cadmium  poisoning in man (84) and rabbits 
(85), and in rats with mercuric chloride-induced  renal tubular damage (83). A 70- to 
100-fold increase in the lysozyme content of kidney tissue was found by Perri and 
associates  (86, 87) in rats bearing  the Jensen sarcoma. Initially, the increased lyso- 
zyme was considered to be specifically related to the Jensen tumor, but subsequent 
studies  (88, 89) demonstrated comparable increases in kidney lysozyme with other 
transplanted neoplasms, and it was concluded that the lysozyme was related to the 
reticuloendothelial  and macrophage response to the tumor, rather than to the tumor 
per se. In studies of lysozyme levels in postmortem samples of kidneys of 29 human 
cancer subjects, Perri and Faulk (90) could find no consistent patterns. 
In the present studies, we have confirmed an inconsistent increase in urinary 
lysozyme associated with renal disease, particularly pyelonephrifis, of a much 
lower order of magnitude than that associated with monocytic leukemia. 
Lysozyme  and the Leukemias.--With  respect to the  hematologic dyscrasias, 
Finch (91) and Joll~s (32, 92, 93) and their associates have previously reported 
increased serum lysozyme in cases of myelocytic and monocytic leukemia, and 
decreased serum lysozyme in lymphatic leukemia. Urinary lysozyme was not 
examined by these investigators. The present studies have confirmed  the ele- 
vation in serum lysozyme in monocytic and monomyelocytic leukemia and have 
further documented the excretion of large amounts  (0.6 to 2.6 g per day) of 
lysozyme in the urine of these patients. 
In the present studies, a general correlation was evident between the amount 
of enzyme excreted and the absolute monocyte count in the peripheral blood. 
The degree of variability observed in  this  relationship probably reflects the 
multiplicity of factors involved in  the  production, cellular release,  and ulti- 
mate renal excretion of the enzyme. Thus, although lysozyme was demonstrated 
immunologically in buffy coat preparations following the  sonic  disruption  of 
cells,  as shown in Text-fig. 7, it could not be demonstrated in saline washings 
of intact leukocytes. It is  therefore likely that  the lysozyme is primarily re- 
leased when cells disintegrate. At present, it is not known if any enzyme escapes 
from intact cells and whether abnormal monocytes differ from normal cells in 
their quantity of lysozyme or in the manner in which it is released. Following 
release of lysozyme into the circulation, there unquestionably are also several 
additional factors (e.g. tissue binding, renal clearance) involved in its ultimate 
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in small samples should enable elucidation of some of these factors, and these 
studies are in progress. 
Another important question which remains to be clarified concerns the identi- 
fication of the specific population of leukocytes which elaborate lysozyme. From 
the present studies, the cell type which appeared to be most consistently related 
to lysozyme elaboration had the cytologic and staining properties of monocytes. 
It must  be recognized,  however,  that  there  is considerable variability  in  the 
morphologic features of individual  cells of this series which at times makes it 
difficult to distinguish monocytic from immature  granulocytic forms.  Indeed, 
the exact nature of the relationship between these cell lines is still unclear. Un- 
questionably, much of the confusion in the classification of monocytic, mono- 
myelocytic, and myelocytic leukemias relates to these factors and to the limita- 
tions of conventional morphologic criteria. 
Of interest and possible significance is the fact that lysozyme was the only 
enzyme found in excess in the present cases, and that the other hydrolases (i.e. 
acid phosphatase,/~-glucuronidase,  cathepsin,  and ribonuclease)  which are de- 
monstrable  in  mixed  populations  of  leukocytes  and  macrophages  were  not 
found in abnormally high concentration  in the whole urinary protein precipi- 
tates of these patients. By itself, this observation implies the proliferation of a 
population  of cells which has,  either constitutively or as a  consequence of its 
abnormal proliferative (neoplastic) state, the capacity to elaborate lysozyme as 
its principal or sole product. Alternately, it is possible that other enzymes were 
produced in excessive amounts in these cases but not excreted in the urine be- 
cause of different molecular  parameters  (i.e.  greater  size,  charge  differences, 
more rapid catabolism, etc.). These possibilities are presently under  investiga- 
tion. 
Relationship between the Monocytic and Plasmacytlc Dyscrasias.--In certain 
respects, the elaboration of large quantities of lysozyme by proliferating mono- 
cytes in the present cases appears similar to the elaboration of gamma globu- 
lins  and  gamma  globulin  subunits  in  cases  of multiple  myeloma  and  other 
plasma cell dyscrasias. A significant difference, however, is the apparent identity 
of the lysozyme in all the present cases and its identity with the normal enzyme, as 
compared with the structural specificities of the proteins produced in individual 
cases of plasma cell dyscrasia (94). This difference unquestionably relates to the 
heterogeneity  of the normal  immunoglobulln  products  of plasma cells as op- 
posed  to  the  apparent  homogeneity  of  the  enzymes  elaborated  by  specific 
populations of leukocytes. 
Additional  similarities  between the present group of cases and some of the 
plasma cell dyscrasias relate to certain clinical features and possible pathogenic 
mechanisms. 
As previously noted, all the present cases had significant nonspecifie proteinuria in 
addition  to hyperlysozymuria, suggesting  renal  functional  impairment,  and five of ELLIOTT  F.  OSSERMAN  AND  DOLORES  P. LAWLOR  945 
the cases exhibited hypokalemia and  hyperkaluria, indicating renal tubular dysfunc- 
tion possibly  related to the excretion  of the cationic  lysozyme. Detailed renal and 
electrolyte studies are in progress. 
Electrophoretic and immunoelectrophoretic analyses of the serum proteins in 
seven of the present cases demonstrated an increase in gamma globulins, partic- 
ularly gamma-A  globulin,  and in two cases a  small, M-type gamma-G peak 
was present in the serum. As further evidence of a possible association with the 
plasma cell dyscrasias, the first of the present cases has well documented plasma 
cell myeloma with amyloidosis and Bence Jones proteinuria of at  least  4  yr 
duration prior to developing monomyelocytic leukemia as an unexpected termi- 
nal event.* 
The patient's urinary proteins were serially studied to evaluate chemotherapy and 
for a period of 18 months prior to the terminal event, there was a significant decrease 
in  Bence Jones proteinuria  associated  with  l-phenylalanine  mustard  (melphalan, 
'Alkeran')  therapy.  Coincident  with the  terminal development of monomyelocytic 
leukemia,  the cationic protein, ultimately identified  as lysozyme, appeared in  the 
u~ne. 
As previously reported (95), the plasma cell dyscrasia developed in this case 
against a background of long-standing urinary tract infection, and the possibil- 
ity that the chronic infection might have induced the plasma cell dyscrasia was 
suggested (95). The sequence of events in this case, and the fact that significant 
chronic infections were documented as antecedent illnesses in five other cases in 
the present series has suggested the possibility of the operation of pathogenic 
mechanisms similar to those postulated for certain of the plasma cell dyscrasias 
(96). Further detailed clinical and  pathologic studies are in progress in an ef- 
fort to elucidate these mechanisms. 
SD'MM~Ry 
Markedly increased quantities of lysozyme have been found in the serum and 
urine (ranging to 2.6 g per day) of ten consecutive cases of monocytic and mono- 
myelocytic leukemia. The enzyme has been isolated from the urine of several 
cases  and  physicochemically and  immunochemically characterized.  It  is  ap- 
parently identical  to  the  lysozyme  of normal  tears,  saliva,  leukocytes, and 
serum, but structurally different from  the lysozyme of hen's egg white.  The 
activity of the human enzyme assayed with M. lysodeikticus organisms is 3 to 
12 times greater than egg white lysozyme at equivalent concentrations. 
An agar plate method has been developed for quantitating lysozyme activity 
in  small  samples  (approximately 25  /al) of serum,  urine,  or  other biological 
a A detailed description of this case prior to the terminal event was reported as case 4 (]3. 
Eps.) in a study of amyloidosis  and plasma call dyscrasia (95). 946  SERUM  AND  URINARY  LYSOZYME  IN  LEUKEMIA 
fluids.  The range and reproducibility of this method were found to be superior 
to previously available lysozyme assay procedures. 
Present  evidence  indicates  that  lysozyme  is  the  principal,  if  not  the  sole, 
product  of  the  proliferating  monocytes  in  monocytic  and  monomyelocytic 
leukemia,  and  quantitation  of serum  and  urine  lysozyme  should  be  a  useful 
diagnostic procedure for these leukemias. 
The authors are indebted to Dr. Zanvil Cohn of the Rockefeller University and Dr. Her- 
bert Rosenkranz of the Department of Microbiology for assistance  with the enzyme assays; 
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studies;  and to Dr. Albert Pick,  Mrs.  Ana Tiburcio,  and Mrs.  Mac MacDonald for their 
assistance in assembling the clinical material and samples. 
We also gratefully  acknowledge our appreciation  to Dr. Karl Meyer and Dr. Robert F. 
Loeb for their valuable discussions and suggestions, and to Mrs. Vivian Meyer for assistance 
with the manuscript. 
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EXPLANATION  OF PLATES 
P~  91 
FIG. i. (A to D). Representative peripheral  blood and bone marrow smears of 
monocytic (case 10) and monomyelocytic (case 6) leukemies. Wright Giemsa stain. 
×300. 
A. Peripheral  blood (ease  10). Total white blood cell count,  117,000, with 82% 
monocytic forms. 
B. Bone marrow (case 10). Large monocytic forms with cytoplasmic granules and 
granule-free cytoplasmic buds. 
C. Bone marrow (case 6). Monocytic and myelocytic  forms. Total white blood cell 
count, 68,500, with 40% monocytes, and 42% polymorphonudear  leukocytes. 
D. Bone marrow  (case 6). Large monocytic cells with prominent nudeoli, nuclei 
with vacuoles, and azure-stained cytoplasmic granules; polymorphonuclear leukocytes 
and myelocytes. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 124  ~LATE 91 
FIG.  1 
(Osserman and Lawlor: Serum and urinary lysozyme in leukemia) PLATE 92 
FIG.  2.  Electron photomicrograph of the predominant cell form in the bone mar- 
row of case 3. Enlarged area (B) shows a prominent Golgi zone (Go), scattered endo- 
plasmic reticulum (ER), mitochondria (M), and numerous lysosomal granules (LyG). 
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FIG.  2 
(Osserman and Lawlor: Serum and urinary lysozyme in leukemia) 